Ipsen announces change in R&D leadership: Howard Mayer to retire, succeeded by Christelle Huguet - Ipsen (OTC:IPSEY)

PARIS, FRANCE, 1 September 2023 – Ipsen ((Euronext: IPN, OTC:IPSEY), a global specialty-driven biopharmaceutical company, announced today the appointment of Christelle Huguet as Executive Vice President, Head of

Related Keywords

Switzerland ,United States ,Cambridge ,Cambridgeshire ,United Kingdom ,Germany ,Saclay ,France General ,France ,Massachusetts ,China ,Shanghai ,Paris ,American ,French ,Christelle Huguet ,David Loew ,Howard Mayer ,Institute Pasteur ,Business Development ,Inc Zebiai Therapeutics ,Early Development ,French University Diploma In Technology ,Head Of Research ,Pfizer ,Leadership Team ,Executive Vice President ,Executive Leadership Team ,Chief Executive Officer ,Senior Vice President ,External Innovation ,Rare Disease ,Executive Leadership ,Chief Scientific Officer ,X Chem Inc ,Global Head ,French University Diploma ,European Engineering ,Sponsored Level ,American Depositary Receipt ,